MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
for AML
1 location in Minneapolis
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All·Age: 2 - 75
Code: NCT07493538·Phase 2·Recruiting